327056-65-5 Usage
Uses
Used in Pharmaceutical Research and Development:
2-Pyridinecarboximidamide, N-hydroxy-5-methoxy-(9CI) is used as a chelating agent for metal ions, which is crucial in the development of drugs targeting metal ion-dependent biological processes. Its ability to bind metal ions can help modulate enzyme activities and disrupt metal-dependent pathways, making it a valuable tool in the discovery of new therapeutic agents.
Used in Enzyme Inhibition:
2-Pyridinecarboximidamide, N-hydroxy-5-methoxy-(9CI) is used as an inhibitor of metalloenzymes for its potential to suppress the activity of certain enzymes. This property can be harnessed in the development of drugs that target specific enzymes involved in disease processes, offering a new avenue for the treatment of various conditions.
Used in Chemical Synthesis:
2-Pyridinecarboximidamide, N-hydroxy-5-methoxy-(9CI) can be used as a building block or intermediate in the synthesis of more complex organic compounds, particularly those with potential pharmaceutical or biological applications. Its unique structure and functional groups make it a versatile component in the creation of novel molecules with desired properties.
Used in Analytical Chemistry:
2-Pyridinecarboximidamide, N-hydroxy-5-methoxy-(9CI) can be employed as a reagent or analytical tool in various chemical assays and techniques, such as spectrophotometry or chromatography, to detect or quantify metal ions or other analytes of interest. Its chelating properties can enhance the sensitivity and selectivity of these analytical methods.
Check Digit Verification of cas no
The CAS Registry Mumber 327056-65-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,7,0,5 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 327056-65:
(8*3)+(7*2)+(6*7)+(5*0)+(4*5)+(3*6)+(2*6)+(1*5)=135
135 % 10 = 5
So 327056-65-5 is a valid CAS Registry Number.
327056-65-5Relevant academic research and scientific papers
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
-
, (2008/06/13)
The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
